Search

Search Results

• Clinical and Hematological Predictors of Response to First-Line Therapy in Patients with Diffuse Large B-Cell Lymphoma

  Svetlana Valer’evna Samarina, E.L. Nazarova, N.V. Minaeva, E.N. Zotina, I.V. Paramonov, S.V. Gritsaev

  68-72

  01.01.2019

• Magnetic Resonance Imaging of Bone Marrow and its Results as a Criterion for Administration of Maintenance Therapy After Auto-HSCT in Multiple Myeloma Patients

  Maksim Valer’evich Solov’ev, L.P. Mendeleeva, G.A. Yatsyk, N.S. Lutsik, M.V. Firsova, E.G. Gemdzhian, V.G. Savchenko

  360-367

  01.10.2018

• The Use of Pomalidomide in the Treatment of Relapsed/Refractory Multiple Myeloma in Patients with Renal Failure

  Irina Germanovna Rekhtina, M.V. Nareiko, L.P. Mendeleeva

  283-287

  01.10.2018

• Clinical Experience and Perspectives of Bosutinib Use in Patients with Chronic Myeloid Leukemia

  V.A. Shuvaev, Ol’ga Yur’evna Vinogradova, I.S. Martynkevich, N.V. Novitskaya, M.S. Fominykh, S.N. Tsareva, D.I. Shikhbabaeva, M.M. Pankrashkina, M.V. Chernikov, N.N. Sharkunov, I.I. Zotova, V.Yu. Udal’eva, E.V. Motyko, S.V. Voloshin

  288-294

  01.10.2018

• Correction of Anemia and Evaluation of Efficacy of Red Blood Cell Transfusion in Patients with Oncohematological Diseases

  Nikolai Aleksandrovich Romanenko, A.V. Chechetkin, L.Yu. Zhiguleva, G.V. Grishina, S.V. Bondarchuk, S.S. Bessmel’tsev

  265-272

  01.07.2018

• First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, A.L. Shipaeva, I.V. Matveeva, M.N. Shirokova, A.C. Proskurina, N.A. Red’kina, E.G. Gemdzhyan

  150-159

  01.04.2018

• Epstein-Barr Virus in Patients with Classical Hodgkin’s Lymphoma

  Vladimir Eduardovich Gurtsevitch, E.A. Demina, N.B. Senyuta, I.V. Botezatu, K.V. Smirnova, T.E. Dushen’kina, D.M. Maksimovich, U.V. Paramonova, I.S. Monin, A.V. Lichtenshtein

  160-166

  01.04.2018

• Polymerase Chain Reaction for Prognosis Assessment and Monitoring of the Epstein-Barr Virus-Associated Hodgkin’s Lymphoma

  M.A. Katin, Ivan Viktorovich Zhil’tsov, V.M. Semenov, D.K. Novik

  182-186

  01.04.2018

• Hematopoietic Stem Cell Collection in Multiple Myeloma Patients: Influence of the Lenalidomide-Based Therapy and Mobilization Regimen Prior to Auto-HSCT

  Ivan Ivanovich Kostroma, A.A. Zhernyakova, Zh.V. Chubukina, I.M. Zapreeva, S.A. Tiranova, A.V. Sel’tser, N.Yu. Semenova, S.S. Bessmel’tsev, A.V. Chechetkin, S.V. Gritsaev

  192-197

  01.04.2018

• Efficacy of Chemotherapy in Acute Leukemia Patients Resistant to Previous Standard Treatment According to the Series Measurement of WT1 Gene Expression

  Nikolai Nikolaevich Mamaev, Ya.V. Gudozhnikova, T.L. Gindina, I.M. Barkhatov, A.I. Shakirova, V.A. Katerina, M.V. Gubina, E.S. Nikolaeva, E.V. Semenova, O.V. Paina, E.I. Darskaya, O.V. Pirogova, V.V. Porunova, I.S. Moiseev, I.A. Mikhailova, B.I. Ayubova, V.M. Kravtsova, S.N. Bondarenko, L.S. Zubarovskaya, B.V. Afanas’ev

  78-88

  01.01.2018

• Manufacturing of CD19 Specific CAR T-Cells and Evaluation of their Functional Activity in Vitro

  A.V. Petukhov, V.A. Markova, D.V. Motorin, A.K. Titov, N.S. Belozerova, P.M. Gershovich, A.V. Karabel’skii, R.A. Ivanov, E.K. Zaikova, E.Yu. Smirnov, P.A. Butylin, Andrei Yur’evich Zaritskey

  1-9

  01.01.2018

• Current Opportunities for Treatment Optimization of Mycosis Fungoides and Sezary Syndrome

  Natal’ya Gennad’evna Chernova, O.A. Kolomeitsev

  34-41

  01.01.2018

• Ibrutinib in the Treatment of Relapsed Chronic Lymphocytic Leukemia

  Elena Aleksandrovna Stadnik, N.S. Timofeeva, V.V. Strugov, A.Yu. Zaritskey

  42-49

  01.01.2018

• Conventional and Conformal Radiotherapy with and without Beam Intensity Modulation in Patients with Stage II Hodgkin’s Lymphoma with Supradiaphragmal Lesions

  Yu.N. Vinogradova, E.I. Ivanova, A.I. Chumachenko, E.V. Smirnova, G.I. Andreev, A.M. Kalesnik, N.A. Vorob’ev, N.V. Il’in

  70-77

  01.01.2018

• Prognostic Value of Genetic Markers for Efficacy Estimation of Induction Treatment Including Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients

  Elena L’vovna Nazarova, N.V. Minaeva, M.N. Khorobrykh, E.E. Sukhorukova, V.I. Shardakov, I.V. Paramonov, N.A. Zorina

  54-69

  01.01.2018

• Antibiotic Treatment of Febrile Neutropenia in Patients with Acute Leukemia

  Vladimir Aleksandrovich Okhmat, G.A. Klyasova, E.N. Parovichnikova, V.V. Troitskaya, E.O. Gribanova, V.G. Savchenko

  100-109

  01.01.2018

• First-Line Therapy for Patients with Advanced Hodgkin’s Lymphoma: Efficacy and Toxicity of Intensive ЕАСОРР-14 Program (NN Blokhin National Medical Cancer Research Center Data)

  Elena Andreevna Demina, A.A. Leont’eva, G.S. Tumyan, Yu.E. Ryabukhina, O.P. Trofimova, N.V. Volkova, Yu.I. Pryamikova, V.M. Sotnikov, V.B. Larionova, E.G. Medvedovskaya, E.V. Paramonova, L.V. Manzyuk, N.A. Probatova, N.V. Kokosadze, E.A. Osmanov

  443-452

  01.10.2017

• New Possibilities of Treatment for Relapsed/Refractory Multiple Myeloma: A Literature Review

  Ol’ga Mikhailovna Votyakova

  425-434

  01.10.2017

• Targeted Therapy of Myelofibrosis

  Ol’ga Yur’evna Vinogradova, V.A. Shuvaev, I.S. Martynkevich, M.M. Pankrashkina, M.S. Fominykh, E.V. Efremova, K.Yu. Krutikova, L.B. Polushkina, N.N. Sharkunov, S.V. Voloshin, A.V. Chechetkin

  471-478

  01.10.2017

• Classification of Conditioning Regimens for Bone Marrow Transplantation: Historical Background and Current Perspectives

  Kapitolina Nikolaevna Melkova, G.D. Petrova, N.V. Gorbunova, T.Z. Chernyavskaya, O.P. Trofimova

  494-500

  01.10.2017

• The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity

  Kamil’ Daniyalovich Kaplanov, T.Yu. Klitochenko, A.L. Shipaeva, M.N. Shirokova, I.V. Matveeva, N.B. Lavrishina

  358-365

  01.07.2017

• Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children

  Natal’ya Andreevna Batmanova, M.A. Shervashidze, A.V. Popa, L.Yu. Grivtsova, I.N. Serebryakova, G.L. Mentkevich

  381-389

  01.07.2017

• The Role of Hypomethylating Agents Prior to Allogeneic Hematopoietic Stem Cells Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome

  Varvara Nikolaevna Ovechkina, S.N. Bondarenko, E.V. Morozova, I.S. Moiseev, A.A. Osipova, T.L. Gindina, A.I. Shakirova, T.A. Bykova, A.D. Kulagin, I.A. Samorodova, E.V. Karyakina, E.A. Ukrainchenko, L.S. Zubarovskaya, B.V. Afanas’ev

  351-357

  01.07.2017

• Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice

  Anna Grigor’evna Turkina, N.V. Novitskaya, A.K. Golenkov, V.A. Shuvaev, L.I. Napso, I.V. Krylova, A.M. Savrilova, G.Sh. Safuanova, A.V. Korobkin, T.Yu. Klitochenko, E.V. Burnasheva, E.V. Vasil’ev, O.M. Senderova, E.Yu. Fedorova, L.M. Yalunina, E.K. Nekhai, G.B. Kuchma, A.S. Lyamkina, N.G. Shchedrova

  390-401

  01.07.2017

• Thrombophilia and Pregnancy

  M.V. Galaiko, O.V. Rybina, M.S. Litvinenko, Yu.V. Klimov, B.Yu. Al’tshuler, Andrei Vladimirovich Gubkin

  409-422

  01.07.2017

• Dasatinib in First- and Second-Line Therapy of Chronic Myeloid Leukemia: Efficacy, Safety and Quality of Life

  Tat’yana Ivanovna Ionova, N.B. Bulieva, O.Yu. Vinogradova, T.A. Gritsenko, L.K. Kozlova, G.B. Kuchma, E.G. Lomaia, E.R. Machyulaitene, T.P. Nikitina, N.V. Novitskaya, A.Yu. Rodionova, E.I. Usacheva, T.V. Shneider

  206-217

  01.04.2017

• Effect of IGHV Gene Mutation Status and BCR Structure Stereotypy on Effectiveness of BR Regimen in First-Line Therapy of Chronic Lymphocytic Leukemia

  Vladimir Vladimirovich Strugov, E.A. Stadnik, A.M. Rumyantsev, T.O. Andreeva, Yu.V. Virts, Yu.V. Mirolyubova, P.A. Butylin, A.Yu. Zaritskey

  141-149

  01.04.2017

• Effect of Patients’ Endocrine Status on Effectiveness of Treatment with Rituximab: State of the Art

  Yuliya Valer’evna Komoza, V.A. Komoza, S.V. Chernavskii, O.A. Rukavitsyn

  187-190

  01.04.2017

• Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice

  Irina Ivanovna Zotova, S.V. Gritsaev, E.R. Shilova, N.A. Potikhonova, K.М. Abdulkadyrov, A.V. Chechetkin

  93-100

  01.01.2017

• Features of Imaging of Different Types of Hodgkin’s Lymphoma Using Combined Positron Emission and Computed Tomography

  Aleksei Sergeevich Subbotin, N.G. Afanas’eva

  61-64

  01.01.2017

• Role of Positron-Emission Tomography in Prognosis of Outcomes of High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Hodgkin’s Lymphoma

  Vsevolod Gennad’evich Potapenko, N.B. Mikhailova, B.I. Smirnov, I.A. Skorokhod, D.A. Chaginskaya, V.V. Ryabchikova, I.A. Samorodova, E.I. Podol’tseva, V.V. Ipatov, I.V. Boikov, V.N. Semelev, D.A. Gornostaev, T.G. Potapenko, T.G. Kulibaba, N.V. Medvedeva, B.V. Afanas’ev

  406-412

  01.10.2016

• Factors Affecting Course and Outcome of Chronic Lymphocytic Leukemia: Data from Hematological Hospitals of Krasnoyarsk Region

  Varvara Ivanovna Bakhtina, I.V. Demko, A.N. Narkevich, D.S. Gushchin

  413-419

  01.10.2016

• WT1 Gene Overexpression in Oncohematological Disorders: Theoretical and Clinical Aspects (Literature Review)

  Nikolai Nikolaevich Mamaev, Ya.V. Gudozhnikova, A.V. Gorbunova

  257-264

  01.07.2016

• Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis

  M.V. Barabanshchikova, E.V. Morozova, V.V. Baikov, I.M. Barkhatov, N.N. Mamaev, S.N. Bondarenko, A.L. Alyanskii, Lyudmila Stepanovna Zubarovskaya, B.V. Afanas’ev

  279-286

  01.07.2016

• Plerixafor in Patients with Decreased Mobilizing Ability of Autologous Hematopoietic Stem Cells

  Maksim Anatol’evich Kucher, М.S. Motalkina, О.U. Klimova, Е.V. Kondakova, О.B. Kalashnikova, S.М. Alekseev, D.V. Motorin, D.V. Babenetskaya, E.I. Podol’tseva, N.B. Mikhailova, М.А. Estrina, Е.V. Babenko, A.Yu. Zaritskii, B.V. Afanas’ev

  155-161

  01.04.2016

• Role of Patient’s Age and Comorbidities in Therapy of Chronic Lymphocytic Leukemia

  Vladimir Vladimirovich Strugov, E.A. Stadnik, Yu.V. Virts, T.O. Silina, A.Yu. Zaritskii

  162-175

  01.04.2016

• NK-Cell Lymphoblastic Leukemia/Lymphoma (Literature Review and Authors’ Experience)

  M.A. Frenkel’, O.Yu. Baranova, Alina Sergeevna Antipova, N.A. Kupryshina, N.N. Tupitsyn

  208-217

  01.04.2016

• Prognostic Significance of Thymidine Kinase-1 versus β2-Microglobulin and Lactate Dehydrogenase in Lymphoproliferative Diseases

  Natal’ya Konstantinovna Parilova, N.S. Sergeeva, N.V. Marshutina, N.G. Tyurina, I.S. Meisner

  6-12

  01.01.2016

• Malignant Lymphoproliferative Disorders with Anemia: Changes of Quality of Life in Patients Treated with Donor Red Blood Cell Transfusions and Recombinant Erythropoietin

  Stanislav Semenovich Bessmel’tsev, N.A. Romanenko, N.A. Potikhonova, S.A. Tiranova, M.N. Zenina, A.E. Romanenko, L.Yu. Zhiguleva, K.M. Abdulkadyrov

  368-378

  01.10.2015

• Diagnostic Value of C-Reactive Protein as Marker of Infections in Patients with De Novo Acute Myeloid Leukemias

  Lyudmila Nikolaevna Tarasova, S.G. Vladimirova, V.V. Cherepanova

  442-446

  01.10.2015